Proxy | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  167989 of 168914  at  9/29/2022 7:34:40 PM  by

ZFP


 In response to msg 164833 by  ZFP
view thread

Re: Proxy

Reiterated that they have been contacted for new potential collaborations during fireside chat today for:
- novel capsid program
- Tregs

McClung stated that the ZFP-TF CNS engineering is relatively straight forward and easy but delivery remains the obstacle. With Prion as the lead owned program and 3 other undisclosed owned programs, they need to identify the capsid for NHP studies appropriate to move into human studies. Said they had explored other capsids specifically mentioning Voyager. Wonder if this is tied back to the Biogen deal signed with Voyager.

Also referenced the Allogeneic 2 platform (both iPSC and editing driven) for CAR Tregs but no detail.



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 12  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...